Theravance Biopharma Inc (TBPH)
$10.04 -$0.10 (-0.99%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$485.84M -
Day's Range
$9.96 - $10.10 -
Volume
214,190 -
52 Week Low / High
$7.44 - $11.71 -
PE Ratio
- -
PEG Ratio
-0.05 -
Dividend Frequency
-
TBPH's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 1
- Buy
- 3
- Hold
- 0
- Sell
- 0
- Strong Sell
- $13.40
- Target Price
Company News
-
Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long — Jan 19th, 2024
Theravance Biopharma, Inc. (NASDAQ:TBPH) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United St...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$